Luis Correa Luna, MD
Internal Medicine · Sanford, FLNPI 1497721641
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $411,890 of the $411,911 with a category attached, or 100.0%. Kedplasma LLC accounts for 98.6% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $108,000, more than ten times the $4,051 reported in 2019. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $2709.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kedplasma LLC$406K
- CSL Behring$6K
- Amarin Pharma, Inc.$21
What the payments were for
- Consulting fees$411,890100%
- Food & beverage$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kedplasma LLC | 143 | $406,000 |
| CSL Behring | 8 | $5,890 |
| Amarin Pharma, Inc. | 1 | $21 |
How this compares
$411,911 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $39,336 |
| OzempicSemaglutide | 31 | $36,238 |
| MounjaroTirzepatide | 31 | $33,104 |
| JardianceEmpagliflozin | 20 | $18,485 |
| TrulicityDulaglutide | 13 | $12,853 |
| SymbicortBudesonide/Formoterol Fumarate | 32 | $8,621 |
| JanuviaSitagliptin Phosphate | 16 | $7,854 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $5,242 |
| Aspirin-Dipyridamole ErAspirin/Dipyridamole | 11 | $3,458 |
| Celecoxib | 23 | $1,627 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $1,537 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 15 | $1,501 |
| Mirtazapine | 26 | $1,237 |
| Atorvastatin Calcium | 128 | $1,223 |
| Duloxetine Hcl | 28 | $1,105 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Sanford
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
- Richard AguilarMiami$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.